CureVac

CureVac is a biotechnology company that develops innovative vaccines and therapies using messenger RNA (mRNA) technology. This approach involves creating synthetic strands of mRNA that instruct cells in the body to produce specific proteins, such as those needed to trigger an immune response against diseases like COVID-19. Unlike traditional vaccines, mRNA vaccines do not contain live viruses and can be developed quickly. CureVac's work aims to create effective, adaptable vaccines and treatments for infectious diseases, cancer, and other conditions, leveraging advances in genetic science to improve health outcomes globally.